Ignite Creation Date:
2024-05-06 @ 10:21 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03235401
Status:
UNKNOWN
Last Update Posted:
2017-08-01
First Post:
2017-07-28
Brief Title:
The PAH Disability and Bothersomeness Questionnaire
Sponsor:
Association de Recherche en Physiopathologie Respiratoire
Organization:
Association de Recherche en Physiopathologie Respiratoire
Study Overview
Official Title:
Validation of a Questionnaire Assessing Disability and Bothersomeness in Pulmonary Arterial Hypertension PAH The PAH Disability and Bothersomeness Questionnaire
Status:
UNKNOWN
Status Verified Date:
2017-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PAH-DBoQ
Brief Summary:
To develop a patient-reported questionnaire to investigate the impact of PAH pulmonary arterial hypertension on patients daily lives in terms of bothersomeness and disability
Detailed Description:
A 3-steps study protocol was initiated in 2011 to develop a patient reported outcome measure PROM in PAHThe first two steps have been completed qualitative study and Delphi consensus study leading to the development of a provisional 37-items questionnaire A reduction of items in this provisional questionnaire and the validation of the final questionnaire are the goals of the current study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None